“Functional Equivalence” Upheld In Court; Amgen Cannot Challenge Decision
Executive Summary
The Centers for Medicare & Medicaid Services has the authority to enforce its position that Amgen's Aranesp is "functionally equivalent" to J&J's Procrit for reimbursement purposes, a D.C. federal appeals court ruled
You may also be interested in...
CMS Will Focus On Value, Not Price, Of Medicines, McClellan Pledges
Medicare reimbursement should be based on the "value" of medicines, not their price, incoming Centers for Medicare & Medicaid Services Administrator Mark McClellan told the Senate Finance Committee in a 1written Q&A exchange
CMS Will Focus On Value, Not Price, Of Medicines, McClellan Pledges
Medicare reimbursement should be based on the "value" of medicines, not their price, incoming Centers for Medicare & Medicaid Services Administrator Mark McClellan told the Senate Finance Committee in a 1written Q&A exchange
“Innovation Criteria” Could Help Focus Health Spending, J&J Exec Suggests
Policymakers should attempt to define "innovation criteria" to help guide health care resources toward more significant technological advances, Johnson & Johnson Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia